Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping

NCT06048458 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT06048458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06048458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
May 18, 2022
Completion date
February 29, 2024
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, cardiovascular diseases, colorectal cancer, fluorouracil adverse reaction, gastric cancer, malignancy, oesophagus cancer, pancreatic cancer